Ancilia develops novel bacterial therapies that target the viral components of the microbiome to address chronic diseases across immunology and oncology indications. Our approach harnesses the natural function of CRISPR to enhance bacterial immunity against viruses and effectively modulate the human microbiome.
View Top Employees from Ancilia BiosciencesWebsite | http://www.anciliabio.com |
Employees | 13 (8 on RocketReach) |
Founded | 2019 |
Industry | Biotechnology |
Looking for a particular Ancilia Biosciences employee's phone or email?
David Páez-Espino is the CTO of Ancilia Biosciences.
8 people are employed at Ancilia Biosciences.